Henoch-Schönlein purpura overview: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Template:Henoch-Schonlen purpura}} == Overview == In medicine (rheumatology and pediatrics) '''Henoch-Schönlein purpura''' (HSP, also known as ''alle..." |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Template:Henoch- | {{Template:Henoch-Schönlen purpura}} | ||
{{CMG}} | |||
== Overview == | == Overview == | ||
In [[medicine]] ([[rheumatology]] and [[pediatrics]]) '''Henoch-Schönlein purpura''' (HSP, also known as ''allergic purpura'') is a systemic [[vasculitis]] (inflammation of blood vessels) characterized by deposition of [[immune complex]]es containing the antibody [[IgA]], especially in the skin and kidney. It occurs mainly in children. Typical symptoms include palpable [[purpura]] (small hemorrhages in the skin), [[arthralgia|joint pains]] and [[abdominal pain]]. Most cases are self-limiting and require no treatment apart from symptom control, but the disease may relapse (in 33% of cases) and cause irreversible kidney damage (in 1%).<ref name=Saulsbury2001>{{cite journal |author=Saulsbury FT |title=Henoch-Schönlein purpura |journal=Curr Opin Rheumatol |volume=13|issue=1 |pages=35–40 |year=2001 |pmid=11148713 |doi=}}</ref> | |||
==References== | |||
{{reflist|2}} | |||
{{WH}} | |||
{{WS}} |
Revision as of 16:12, 23 August 2012
Template:Henoch-Schönlen purpura Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
In medicine (rheumatology and pediatrics) Henoch-Schönlein purpura (HSP, also known as allergic purpura) is a systemic vasculitis (inflammation of blood vessels) characterized by deposition of immune complexes containing the antibody IgA, especially in the skin and kidney. It occurs mainly in children. Typical symptoms include palpable purpura (small hemorrhages in the skin), joint pains and abdominal pain. Most cases are self-limiting and require no treatment apart from symptom control, but the disease may relapse (in 33% of cases) and cause irreversible kidney damage (in 1%).[1]